Drug Trial Radar · NCT05834868
Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes
Last checked: Nov 19, 2026Latest source record: Dec 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,040
Actual
Start
May 6, 2022
Primary completion
Dec 10, 2024
Study completion Dec 31, 2024
Sponsor
- Lead sponsor
- Tonghua Dongbao Pharmaceutical Co.,LtdIndustry
- Sponsor type
- Industry
- First posted
- Apr 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 26-week randomized, open-label, multicenter, active-controlled parallel group trial. The purpose of this study is to compare efficacy and safety of THDB0206 injection with insulin lispro injection combined with insulin glargine injection U-100 in Chinese participants with T2DM.
Conditions
- Type 2 Diabetes
Interventions
THDB0206 InjectionDrug
Drug: THDB0206 Injection Injected subcutaneously three times a day. Dose was individually adjusted.
Insulin Lispro InjectionDrug
Drug:Insulin Lispro Injection Injected subcutaneously three times a day. Dose was individually adjusted.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Glycosylated Haemoglobin (HbA1c) After 26 Weeks of TreatmentTime frame: Week 26
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Zhongshan Hospital
Shanghai, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.